/NOT FOR DISTRIBUTION TO UNITED
STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION,
DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR
IN PART, IN OR INTO THE UNITED
STATES./
Assure Begins Work With Prominent Vascular
Group
PARKER, CO, Sept. 19, 2017 /CNW/ - Assure Holdings
Corp. (the "Company" or "Assure") (TSXV: IOM; OTCBB: ARHH),
announces today that it has recently begun working with and
performing intraoperative neuromonitoring (IONM) for a premier
group of vascular surgeons in the Denver area. Vascular surgeons specialize in
surgical treatment of the arteries that are critical circulatory
pathways throughout the body. Assure's technologists are able to
use their same equipment and skill set in vascular surgeries, just
as they do in spine surgery, to monitor nerves and brain function
in real time.
Preston Parsons, Founder and CEO
of Assure commented, "This marks a very significant step in the
evolution of the company. Vascular surgery is a vastly underserved
part of the IONM market. We are pleased to have technologists with
the level of knowledge and skill needed to participate in these
complicated surgeries."
Vascular surgery comprises about 1/3 of the IONM market in
the United States. The most common
vascular surgeries include carotid surgery and aortic surgery. IONM
is also being adopted in other vascular procedures as the
technology is more universally recognized as improving patient
outcomes.
Numerous vascular procedures place one or more aspects of the
patient's nervous system at risk, either from direct surgical
manipulation or ischemia secondary to the vascular procedure being
preformed. IONM can help assess these neural structures
during the vascular procedure to help ensure the safety and
functionality of the nervous structures. For example, during
a Carotid Endarterectomy blood flow through the operative carotid
artery is occluded, decreasing the overall blood flow to the brain.
IONM is utilized during this procedure to help ensure that adequate
perfusion of the cerebral cortex is maintained. Overall, IONM
provides invaluable information to vascular surgeons regarding
functionality of nervous structures placed at risk from the
vascular operation.
Parsons continued, "Furthermore, now that we have expanded into
vascular surgery, our current addressable market has increased
significantly and has helped pave the way for future expansion into
this underserved surgical vertical."
About Assure Holdings Corp.
Assure Holdings Corp. is a Colorado based company that
works with neurosurgeons and orthopedic spine surgeons to provide a
turnkey suite of services that support intraoperative
neuromonitoring activities during invasive surgeries. Assure:
(i) employs its own staff of technologists and uses its own state
of the art monitoring equipment, (ii) handles 100% of
intraoperative neuromonitoring scheduling and setup, and (iii)
bills for all technical services provided. While Assure
focuses primarily on supporting spinal surgeries, plans are in
place to support other classes of medicine that rely on the
standard of care that intraoperative neuromonitoring provides.
Neither the TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in the policies of the
TSX Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
The securities of the Corporation have not been and will
not be registered under the United States Securities Act of 1933,
as amended and may not be offered or sold in the United
States absent registration or an applicable exemption from the
registration requirement. This press release shall not constitute
an offer to sell or the solicitation of an offer to buy nor shall
there be any sale of the securities in any jurisdiction in which
such offer, solicitation or sale would be unlawful.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING
INFORMATION: This news release contains certain statements that
may constitute forward-looking information under applicable
securities laws. All statements, other than those of historical
fact, which address activities, events, outcomes, results,
developments, performance or achievements that Assure anticipates
or expects may or will occur in the future (in whole or in part)
should be considered forward-looking information. Such information
may involve, but is not limited to, comments with respect to
strategies, expectations, planned operations and future actions of
the Company. Often, but not always, forward-looking information can
be identified by the use of words such as "plans", "expects", "is
expected", "budget", "scheduled", "estimates", "forecasts",
"intends", "anticipates", or "believes" or variations (including
negative variations) of such words and phrases, or statements
formed in the future tense or indicating that certain actions,
events or results "may", "could", "would", "might" or "will" (or
other variations of the forgoing) be taken, occur, be achieved, or
come to pass. Forward-looking information is based on currently
available competitive, financial and economic data and operating
plans, strategies or beliefs as of the date of this news release,
but involve known and unknown risks, uncertainties, assumptions and
other factors that may cause the actual results, performance or
achievements of Assure to be materially different from any future
results, performance or achievements expressed or implied by the
forward-looking information. Such factors may be based on
information currently available to Assure, including information
obtained from third-party industry analysts and other third party
sources, and are based on management's current expectations or
beliefs regarding future growth, results of operations, future
capital (including the amount, nature and sources of funding
thereof) and expenditures. Any and all forward-looking information
contained in this press release is expressly qualified by this
cautionary statement.
SOURCE Assure Holdings Corp.
